Kyverna Therapeutics Statistics

Total Valuation

KYTX has a market cap or net worth of $141.76 million. The enterprise value is -$93.95 million.

Market Cap	141.76M
Enterprise Value	-93.95M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

KYTX has 43.22 million shares outstanding. The number of shares has increased by 6,313.09% in one year.

Current Share Class	43.22M
Shares Outstanding	43.22M
Shares Change (YoY)	+6,313.09%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	2.26%
Owned by Institutions (%)	32.54%
Float	22.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.56
P/TBV Ratio	0.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.44, with a Debt / Equity ratio of 0.03.

Current Ratio	7.44
Quick Ratio	7.29
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,315.07

Financial Efficiency

Return on equity (ROE) is -49.72% and return on invested capital (ROIC) is -33.54%.

Return on Equity (ROE)	-49.72%
Return on Assets (ROA)	-31.08%
Return on Invested Capital (ROIC)	-33.54%
Return on Capital Employed (ROCE)	-71.14%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	112
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-54.88%
50-Day Moving Average	2.57
200-Day Moving Average	3.64
Relative Strength Index (RSI)	57.50
Average Volume (20 Days)	572,418

Short Selling Information

The latest short interest is 2.10 million, so 4.86% of the outstanding shares have been sold short.

Short Interest	2.10M
Short Previous Month	2.09M
Short % of Shares Out	4.86%
Short % of Float	9.46%
Short Ratio (days to cover)	4.51

Income Statement

Revenue	n/a
Gross Profit	-127.43M
Operating Income	-161.75M
Pretax Income	n/a
Net Income	-145.42M
EBITDA	-160.55M
EBIT	-161.75M
Earnings Per Share (EPS)	-$3.37

Full Income Statement

Balance Sheet

The company has $242.65 million in cash and $6.94 million in debt, giving a net cash position of $235.71 million or $5.45 per share.

Cash & Cash Equivalents	242.65M
Total Debt	6.94M
Net Cash	235.71M
Net Cash Per Share	$5.45
Equity (Book Value)	224.01M
Book Value Per Share	5.18
Working Capital	214.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$133.64 million and capital expenditures -$1.66 million, giving a free cash flow of -$135.30 million.

Operating Cash Flow	-133.64M
Capital Expenditures	-1.66M
Free Cash Flow	-135.30M
FCF Per Share	-$3.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6,313.09%
Shareholder Yield	-6,313.09%
Earnings Yield	-102.58%
FCF Yield	-95.45%

Analyst Forecast

The average price target for KYTX is $19.00, which is 479.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.00
Price Target Difference	479.27%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	0.18%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2